| Year |
Citation |
Score |
| 2022 |
Rana RR, Rajasekaran K, Knappertz V, Gray RA. Pharmacodynamic synergism contributes to the antiseizure action of cannabidiol and clobazam. Experimental Neurology. 114286. PMID 36442674 DOI: 10.1016/j.expneurol.2022.114286 |
0.307 |
|
| 2019 |
Jakkamsetti V, Marin-Valencia I, Ma Q, Good LB, Terrill T, Rajasekaran K, Pichumani K, Khemtong C, Hooshyar MA, Sundarrajan C, Patel MS, Bachoo RM, Malloy CR, Pascual JM. Brain metabolism modulates neuronal excitability in a mouse model of pyruvate dehydrogenase deficiency. Science Translational Medicine. 11. PMID 30787166 DOI: 10.1126/Scitranslmed.Aan0457 |
0.362 |
|
| 2018 |
Joshi S, Rajasekaran K, Hawk KM, Chester SJ, Goodkin HP. Status Epilepticus: Role for etiology in determining response to benzodiazepines. Annals of Neurology. PMID 29572918 DOI: 10.1002/Ana.25213 |
0.548 |
|
| 2017 |
Joshi S, Sun H, Rajasekaran K, Williamson J, Perez-Reyes E, Kapur J. A novel therapeutic approach for treatment of catamenial epilepsy. Neurobiology of Disease. 111: 127-137. PMID 29274741 DOI: 10.1016/J.Nbd.2017.12.009 |
0.706 |
|
| 2017 |
Joshi S, Rajasekaran K, Williamson J, Kapur J. Neurosteroid-sensitive δ-GABAA receptors: A role in epileptogenesis? Epilepsia. 58: 494-504. PMID 28452419 DOI: 10.1111/Epi.13660 |
0.648 |
|
| 2017 |
Joshi S, Rajasekaran K, Sun H, Williamson J, Kapur J. Enhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus. Neurobiology of Disease. PMID 28377128 DOI: 10.1016/J.Nbd.2017.03.017 |
0.696 |
|
| 2015 |
Zanelli SA, Rajasekaran K, Grosenbaugh DK, Kapur J. Increased excitability and excitatory synaptic transmission during in vitro ischemia in the neonatal mouse hippocampus. Neuroscience. 310: 279-89. PMID 26404876 DOI: 10.1016/j.neuroscience.2015.09.046 |
0.496 |
|
| 2015 |
Joshi S, Rajasekaran K, Hawk KM, Brar J, Ross BM, Tran CA, Chester SJ, Goodkin HP. Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal. Epilepsia. 56: 1355-65. PMID 26248944 DOI: 10.1111/Epi.13098 |
0.599 |
|
| 2013 |
Rajasekaran K, Joshi S, Kozhemyakin M, Todorovic MS, Kowalski S, Balint C, Kapur J. Receptor trafficking hypothesis revisited: plasticity of AMPA receptors during established status epilepticus. Epilepsia. 54: 14-6. PMID 24001062 DOI: 10.1111/Epi.12266 |
0.68 |
|
| 2013 |
Kozhemyakin M, Rajasekaran K, Todorovic MS, Kowalski SL, Balint C, Kapur J. Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus. Neurobiology of Disease. 54: 94-104. PMID 23473742 DOI: 10.1016/J.Nbd.2013.02.015 |
0.649 |
|
| 2013 |
Joshi S, Rajasekaran K, Kapur J. GABAergic transmission in temporal lobe epilepsy: the role of neurosteroids. Experimental Neurology. 244: 36-42. PMID 22101060 DOI: 10.1016/J.Expneurol.2011.10.028 |
0.673 |
|
| 2012 |
Rajasekaran K, Todorovic M, Kapur J. Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus. Annals of Neurology. 72: 91-102. PMID 22829271 DOI: 10.1002/Ana.23570 |
0.621 |
|
| 2011 |
Rajasekaran K, Goodkin HP. A swell in the armamentarium of antiepileptic drug targets. Epilepsy Currents / American Epilepsy Society. 11: 172-6. PMID 22131899 DOI: 10.5698/1535-7511-11.6.172 |
0.33 |
|
| 2010 |
Rajasekaran K, Zanelli SA, Goodkin HP. Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus. Seminars in Pediatric Neurology. 17: 136-43. PMID 20727481 DOI: 10.1016/J.Spen.2010.06.002 |
0.427 |
|
| 2010 |
Rajasekaran K, Joshi S, Sun C, Mtchedlishvilli Z, Kapur J. Receptors with low affinity for neurosteroids and GABA contribute to tonic inhibition of granule cells in epileptic animals. Neurobiology of Disease. 40: 490-501. PMID 20682339 DOI: 10.1016/J.Nbd.2010.07.016 |
0.689 |
|
| 2010 |
Kozhemyakin M, Rajasekaran K, Kapur J. Central cholinesterase inhibition enhances glutamatergic synaptic transmission. Journal of Neurophysiology. 103: 1748-57. PMID 20107127 DOI: 10.1152/Jn.00949.2009 |
0.604 |
|
| 2009 |
Rajasekaran K, Sun C, Bertram EH. Altered pharmacology and GABA-A receptor subunit expression in dorsal midline thalamic neurons in limbic epilepsy. Neurobiology of Disease. 33: 119-32. PMID 18992345 DOI: 10.1016/J.Nbd.2008.09.023 |
0.477 |
|
| 2007 |
Rajasekaran K, Kapur J, Bertram EH. Alterations in GABA(A) receptor mediated inhibition in adjacent dorsal midline thalamic nuclei in a rat model of chronic limbic epilepsy. Journal of Neurophysiology. 98: 2501-8. PMID 17855591 DOI: 10.1152/Jn.00139.2007 |
0.637 |
|
| 2005 |
Rajasekaran K. Seizure-induced oxidative stress in rat brain regions: blockade by nNOS inhibition. Pharmacology, Biochemistry, and Behavior. 80: 263-72. PMID 15680179 DOI: 10.1016/J.Pbb.2004.11.007 |
0.419 |
|
| 2003 |
Rajasekaran K, Jayakumar R, Venkatachalam K. Increased neuronal nitric oxide synthase (nNOS) activity triggers picrotoxin-induced seizures in rats and evidence for participation of nNOS mechanism in the action of antiepileptic drugs. Brain Research. 979: 85-97. PMID 12850575 DOI: 10.1016/S0006-8993(03)02878-6 |
0.474 |
|
| 2001 |
Paul V, Subramanian EH, Rajasekaran K. Pharmacological evidence for a role of gamma-aminobutyric acid A receptor mechanism in modulating nitric oxide synthase activity in rat brain. Neurochemistry International. 38: 209-11. PMID 11099778 DOI: 10.1016/S0197-0186(00)00081-4 |
0.401 |
|
| Show low-probability matches. |